hotspot -WSS

hotspot

author：entertainment 2025-08-12 06:45:00 - browse：6631

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Police still searching for prisoner who escaped from NYC hospital

WSS

ADCs take center stage as promising cancer treatments

ADCs take center stage as promising cancer treatments

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Wegovy trial has doctors encouraged over new possibilities

CZI to create biohub to build anti

American woman, child freed after being kidnapped in Haiti last month

focus

hotspot

explore

After affirmative action ruling, medical educators look to 'holistic review'

ADCs take center stage as promising cancer treatments

Anesthesiologist group: stop taking Ozempic before surgery

ADCs take center stage as promising cancer treatments

Alkermes shareholders re

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Trump demands the U.S. pay no more for drugs than other countries … again

Methadone doses haven’t kept up in the age of fentanyl

DIEP, the 'gold standard' of breast reconstruction, is under threat

Roche acquires Telavant from Roivant, adding experimental IBD treatment

hotspot

South Korea throws huge K

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

American woman, child freed after being kidnapped in Haiti last month

A biotech analyst on neuroscience, placebo effect, not over

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Roche acquires Telavant from Roivant, adding experimental IBD treatment

hotspot

hotspot

focus

hotspot